Journal
BIOCHEMICAL PHARMACOLOGY
Volume 215, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2023.115743
Keywords
Derivative; Metformin; Prodrug; Sulfonamide; Sulfenamide
Categories
Ask authors/readers for more resources
Metformin has been widely used to treat diabetes mellitus due to its safety profile and low cost. However, its pharmacokinetics vary among patients, and its poor oral absorption leads to high therapeutic doses and unpleasant gastrointestinal side effects. Novel derivatives of metformin have been synthesized, especially after the identification of organic cation transporters as its main carriers. These derivatives have shown potential in the treatment of various diseases, including cancers and neurodegenerative diseases.
Metformin has been used for ages to treat diabetes mellitus due to its safety profile and low cost. However, metformin has variable pharmacokinetics in patients, and due to its poor oral absorption, the therapeutic doses are relatively high, causing unpleasant gastrointestinal adverse effects. Therefore, novel derivatives of metformin have been synthesized during the past decades. Particularly, after the mid-2000 s, when organic cation transporters were identified as the main metformin carriers, metformin derivatives have been under intensive investigation. Nevertheless, due to the biguanide structure, derivatives of metformin have been challenging to synthesize. Moreover, the mechanisms of metformin's action are not fully understood to date, and since it has multifunctional properties, the interests have switched to re-purposing for other diseases. Indeed, metformin derivatives have been demonstrated in many cases to be more effective than metformin itself and have the potential to be used in different diseases, including several types of cancers and neurodegenerative diseases. On the other hand, the pleiotropic nature of metformin and its derivatives can also create challenges. Not all properties are fit for all diseases. In this review, the history of the development of metformin-like compounds is summarized, and insights into their potential for future drug discovery are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available